Drug-resistance amino acids known in HIV-1 [36] are shown in bold. Amino acids that are the same as those of the reference HIV-1 HXB2 are shown as bars. † Consensus amino acid sequences were ...

For people with drug-resistant infections, a monoclonal antibody came out in 2018 for use along with other HIV medications.

Now new laboratory work in Canada sheds light on the vulnerabilities of HIV's pockets of resistance in the body, and potential ways to thwart them. Led by Université de Montréal medical ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

If you miss doses, you could develop drug-resistant strains of HIV, and your medication may stop working. Some other medicines and supplements don't mix well with HIV drugs, so make sure you tell ...

There are biological and clinical questions facing the field of HIV genotyping such as the need to better define the level of sensitivity required to detect drug-resistant variants, how different ...

However, researchers acknowledge it is likely that the two participants in the lenacapavir group who contracted HIV developed a certain resistance from the sole use of lenacapavir. This may need ...

"In the cases of HIV cure, the patients received donor immune cells that were resistant to HIV infection because the donor cells lacked a protein that HIV requires to infect the cell," she said.